ArticleTherapeutic advances in musculoskeletal disease2022

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA.

Tomas Milota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.